News

Vince Venditto, PhD, assistant professor in the UK College of Pharmacy’s Department of Pharmaceutical Science, has extensive expertise in vaccine design. He was trained in organic synthesis and vaccine development. He is currently working on a clinical trial with community pharmacies to understand the prevalence of SARS-CoV-2 in Kentucky.

A new University of Kentucky study provides direct evidence for a testing strategy that could be used to support a shortened period of quarantine for university students who are exposed to the virus but are asymptomatic.

In our third and final part of this interview, we ask Vince and Brooke about how this pandemic possibly ends, and how we progress into a new world after COVID-19.

It has been nearly one year since the SARS-CoV-2 coronavirus changed the world. With millions of people infected and over a quarter-million dead in the United States, the novel coronavirus continues its pervasive hold on our health and well-being.

It has been nearly one year since SARS-COV-2 (COVID-19) changed the world. With millions of people infected and over a quarter-million dead in the United States (U.S.), the novel coronavirus continues its pervasive hold on our health and well-being.

“We have the expertise and equipment to advance testing procedures and understand more about the virus’ presence in wastewater—gaining knowledge that can help not only our local community, but also areas around the world that may lack testing infrastructure.”

Anyone over the age of 18 is invited to complete a short survey from Wellness, Health, & You (WHY), an ongoing research project that seeks to understand how different life experiences affect wellbeing and health.

Janssen’s AdVac® technology was used to develop Janssen’s Ebola vaccine regimen and is the basis for its HIV, RSV and Zika vaccine candidates.

Kelly G. Pennell, Gill Associate Professor in the Department of Civil Engineering and director of the UK Superfund Research Center (UK-SRC), has co-authored an article detailing lessons learned about stakeholder engagement and risk communication relevant for COVID-19 and school reopening.

Totaling more than $429 million, the University of Kentucky saw a record-breaking year of research funding for the 2019-20 academic year, a 3% increase from the previous year. UK also continues to climb in national research rankings.